Current breast cancer clinical trials

Home: Educational Supplement: Appendix

Panel Members

Panel Chair: Patricia Eifel, M.D.
Professor of Radiation Oncology
M.D. Anderson Cancer Center
University of Texas
Houston, Texas
John A. Axelson, M.D., FACP
Hematology and Oncology Associates
Jackson, Michigan
Carolyn B. Hendricks, M.D.
Medical Oncologist
Suburban Specialty Care Physicians, P.C.
Bethesda, Maryland
Jose Costa, M.D.
Professor of Pathology and Biology
Director of Anatomic Pathology
Deputy Director, Yale Cancer Center
Vice Chairman, Department of Pathology
Yale University School of Medicine
New Haven, Connecticut
Margaret Kemeny, M.D.
Surgeon
Chief of the Division of Surgical Oncology
University Hospital and Medical Center
State University of New York at
Stony Brook
Stony Brook, New York
John Crowley, Ph.D.
Biostatistician
Fred Hutchinson Cancer Research Center
Seattle, Washington
Alice B. Kornblith, Ph.D.
Director of Outcomes Studies
Department of Pain Medicine and Palliative Care and Cancer Center
Beth Israel Medical Center
New York, New York
Walter J. Curran, Jr., M.D.
Professor and Chairman
Department of Radiation Oncology
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
Thomas A. Louis, Ph.D.
Senior Statistical Scientist
The RAND Corporation
Arlington, Virginia
Ann Deshler, R.N.
Administrative Director
Metro Minnesota CCOP
Institute for Research and Education of HealthSystem Minnesota
St. Louis Park, Minnesota
Maurie Markman, M.D.
Director, The Cleveland Clinic
Taussig Cancer Center
Chairman, Department of Hematology and Medical Oncology
The Lee and Jerome Burkons Research
Chair in Oncology
The Cleveland Clinic Foundation
Cleveland, Ohio
Shirley Fulton, J.D., M.B.A.
Superior Court Judge
Superior Court Judge Office
Charlotte, North Carolina
Debra Roter, Dr.P.H.
Professor, Health Policy and Management
School of Hygiene and Public Health
Johns Hopkins University
Baltimore, Maryland
Robert Mayer, M.D.
Professor of Medicine
Harvard Medical School
Vice Chair for Academic Affairs
Department of Adult Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts
 

 

 

Top | Main Menu

 

Main Menu
Contents
I.
Overview
II.
Factors Used To Select Adjuvant Therapy
III.
Adjuvant Hormone Therapy
IV.
Adjuvant Chemotherapy
V.
Adjuvant Postmastectomy Radiotherapy
VI.
Influences of Treatment-Related Side Effects and Quality-of-Life Issues on Individual Decision-Making About Adjuvant Therapy
Breast Cancer Update's web site
Search our site
Home · Contact us
Terms of use and general disclaimer